Figure Says $300m Prefunded Securitization Gains Certainty
Figure has closed a $300 million fully prefunded securitization for loans to be traded on its Figure Connect marketpl...
Ways To Earn Money By Tonight
Need money by tonight? Discover effective ways to earn quickly and ensure you have the cash you need by the end of the day.
11,165 articles
Tesla’s Chip Breakthrough Deal Signals Big AI Push
Tesla unveils a chip breakthrough deal that could redefine its path from auto maker to AI silicon player. Markets rea...
Sell Micron Stock? Final Verdict: Is Now the Time to Act
Thinking about sell micron stock? final. This guide breaks down the drivers behind MU, risk factors, and a clear verd...
Microsoft vs Nvidia: Which Better AI Stock to Own Now
Two AI giants, Microsoft and Nvidia, offer very different routes to growth. This guide breaks down why one might fit ...
Treasury Income ETFs Attract Retirees as 2-Year Yield Tops 4%
The 2-year Treasury yield has topped 4%, drawing retirees into short-duration income funds. Two ETFs lead the pack, o...
Research Says: Biggest Gains From AI Won’t Be AI Stocks
A fresh look at AI investing shows the most dramatic gains might come from broad market value and international stock...
Bitcoin's Price Tumbled June: Why It's Still a Buy This Summer
June dealt a sharp blow to crypto portfolios, but history suggests volatility can bring opportunity. This guide expla...
Spacex's Massive Deal Could Spark a New Growth Engine
A groundbreaking collaboration could redefine how AI and space tech work together. This article examines what spacex'...
Lemonade Stock Leaped Today: AI Edge and Reinsurance Wins
A surge in Lemonade's stock grabbed attention as investors weighed renewed reinsurance terms and AI-driven growth. Th...
SHLD vs XAR: Should Play the Rearmament Boom in 2026
As defense budgets surge in 2026, SHLD and XAR offer two distinct routes to ride the rearmament boom: a global tech t...
Vertex Paying 102% Premium: Is the Crinetics Deal Worth It?
Vertex is pursuing Crinetics with a substantial all-cash offer. This deep dive breaks down what the $10 billion bid m...
Abbott Labs Glaukos: Which Stock Is Best to Buy in 2026
In 2026, two very different healthcare players—Abbott Laboratories and Glaukos—offer contrasting paths to potential g...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status